ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2026
Frontiers in bacterial outer membrane vesicles: From basic characteristics to cancer therapy.
Article in Chinese journal of cancer research = Chung-kuo yen cheng yen chiu, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bacterial outer membrane vesicles (OMVs) are spherical nanostructures that originate from Gram-negative bacteria. They are gaining attention as powerful tools in cancer diagnostics and therapy due to their unique biological properties. These vesicles, which range from 50 to 250 nm in size, carry molecular components from their parent bacteria, allowing them to play important roles in bacterial defense and microbial ecosystems. Their lipid bilayer structure facilitates targeted drug delivery, while their natural immunogenic properties hold promise for cancer immunotherapy by helping overcome immune evasion in the tumor microenvironment. Moreover, OMVs have potential as biomarkers in liquid biopsies, particularly for cancers associated with bacteria, such as gastric and colorectal cancers. Their ability to interact with the intratumoral microbiota further indicates their relevance in tumor pathogenesis. This review aims to provide a comprehensive overview of the fundamental biology of OMVs and their emerging applications in cancer therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.